Clinical Trials
Tesla BioHealing Impact of Biophoton Therapy on Chronic Severe Arthritis Pain
Butler, PA / ClinicalTrials.gov / Last Update Posted April 07, 2025 — Aimed at easing chronic severe arthritis pain, this randomized, double-blinded clinical trial examines whether biophoton therapy can significantly reduce pain over a 12-week period. The study uses a variety of assessments, including visual analog scales, quality-of-life questionnaires, and inflammatory markers, to gather solid data on treatment effectiveness.
For more details, please read the full study on ClinicalTrials.gov: NCT06915012.
Tesla BioHealing The Impact of Biophoton Therapy on Self-Grown Stem Cells (Stem Cells)
Butler, PA / ClinicalTrials.gov / Last Update Posted March 05, 2025 — In this double-blinded, placebo-controlled study, about 46 volunteers are being evaluated to see if biophoton therapy naturally increases self-grown stem cells. Participants use the treatment over a course of 2 weeks (with a placebo group extending to 4 weeks), while researchers track changes in stem cell counts, pain, and overall quality of life.
For more details, please read the full study on ClinicalTrials.gov: NCT06855459.
Tesla BioHealing Impact of Biophoton Generator on Chronic-Stroke Patients' Recovery
Philadelphia, PA / ClinicalTrials.gov / Last Update Posted July 01, 2024 — This randomized, double-blinded, placebo-controlled trial investigates whether daily use of Tesla BioHealing® Biophoton Generators can help chronic stroke patients regain their independence. The study employs EEG tests and assessments of activities of daily living to objectively measure recovery.
For more details, please read the full study on ClinicalTrials.gov: NCT05898334.
Tesla BioHealing Impact of Biophoton Therapy on Patients With Brain Disorders (Alzheimer)
Butler, PA / ClinicalTrials.gov / Last Update Posted November 30, 2023 — The First Institute of All Medicines is conducting a randomized, triple‐blinded, placebo-controlled study to confirm earlier findings that biophoton therapy is safe and effective for patients with brain disorders. About 80 patients with conditions such as Alzheimer’s, dementia, stroke, traumatic brain injury, and Parkinson’s disease are enrolled to assess improvements in cognitive and overall health.
For more details, please read the full study on ClinicalTrials.gov: NCT06147999.